Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7412806
Reference Type
Journal Article
Subtype
Review
Title
Nephropathic cystinosis: late complications of a multisystemic disease
Author(s)
Nesterova, G; Gahl, W
Year
2008
Is Peer Reviewed?
1
Journal
Pediatric Nephrology
ISSN:
0931-041X
EISSN:
1432-198X
Volume
23
Issue
6
Page Numbers
863-878
Language
English
PMID
18008091
DOI
10.1007/s00467-007-0650-8
Web of Science Id
WOS:000255413700003
Abstract
Cystinosis is a rare autosomal recessive disorder due to impaired transport of cystine out of cellular lysosomes. Its estimated incidence is 1 in 100,000 live births. End-stage renal disease (ESRD) is the most prominent feature of cystinosis and, along with dehydration and electrolyte imbalance due to renal tubular Fanconi syndrome, has accounted for the bulk of deaths from this disorder. Prior to renal transplantation and cystine-depleting therapy with cysteamine for children with nephropathic cystinosis, their lifespan was approximately 10 years. Now, cystinotic patients have survived through their fifth decade, but the unremitting accumulation of cystine has created significant non-renal morbidity and mortality. In this article we review the classic presentation of nephropathic cystinosis and the natural history, diagnosis, and treatment of the disorder's systemic involvement. We also emphasize the role of oral cysteamine therapy in preventing the late complications of cystinosis.
Keywords
cystinosis; nephropathic; complications; lysosomal storage; transport
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity